Suryavathi Viswanadhapalli

机构：Texas A&M University – San Antonio, The University of Texas at San Antonio Health Science Center, Mays Cancer Center at UT Health San Antonio, The University of Texas at San Antonio, The University of Texas Health Science Center at Houston · ORCID：0000-0002-7381-6962

发表论文 252 篇 · 总被引 2169 次 · h-index 24

代表论文

• Midkine (MDK) as a central regulator of the tumor microenvironment: From developmental cytokine to therapeutic target (2026 · Cancer Letters · 被引 13)
• Ferroptosis in Breast Cancer: Molecular Insights and Therapeutic Strategies (2026 · Frontiers in Bioscience-Landmark · 被引 3)
• Tu1972 TRANSLATING ENDOPLASMIC RETICULUM STRESS INTO HEPATOCELLULAR CARCINOMA THERAPY: PRECLINICAL EVALUATION OF ERX-315 (2026 · Gastroenterology)
• Tu1972 TRANSLATING ENDOPLASMIC RETICULUM STRESS INTO HEPATOCELLULAR CARCINOMA THERAPY: PRECLINICAL EVALUATION OF ERX-315 (2026 · Gastrointestinal Endoscopy)
• Midkine Dependency Defines a Therapeutically Actionable Vulnerability in Medulloblastoma (2026 · bioRxiv (Cold Spring Harbor Laboratory))
• Abstract 461: Next-generation ERβ agonists with superior brain uptake suppress glioblastoma and enhance temozolomide response. (2026 · Cancer Research)